The latest report by IMARC Group, titled “Viral Vector Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on viral vector manufacturing market report. The report also includes competitor and regional analysis, and contemporary advancements in the global market. finds that the global viral vector manufacturing market size reached US$ 746.6 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 3,162.5 Million in 2027, expanding at a CAGR of around 25.40% during the forecast period (2022-2027).
Viral vector is the tool for delivering genetic materials into target cells in the field of genetics, vaccinology, and molecular biology. It is used by biologists as a way of replacing malfunctioning genes for curing genetic materials into cells. Viral vector is also exploited for discovering various therapeutic areas as it is manufactured from viruses and animals or insect cell cultures. It aims to target and kill tumor cells, and assist in treating diseases, including metabolic and neurodegenerative disorders. In recent years, viral vector manufacturing has gained prominence due to the rising instances of genetic disorders occurring from gene mutation and defective chromosomes in the body.
|Base Year: 2021|
|Forecast Year: 2022-2027|
Viral Vector Manufacturing Market Trends and Drivers:
The viral vector manufacturing market is primarily driven by the rising demand for several clinical trials due to the prevalence of genetic and infectious diseases and cancer. In addition, the growing consumption of alcohol and sedentary lifestyles of individuals is also fueling the market growth.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/viral-vector-manufacturing-market/requestsample
Besides this, the viral vector is increasingly utilized to discover novel drug delivery as it is an efficient carrier of virus-disabling sequences. It also delivers HIV-inhibiting transgenes to human hematopoietic stem cells (HSCs), thereby escalating the demand for viral vector manufacturing.
Furthermore, the rising demand for advanced clinical treatments and the launch of campaigns by governments to generate awareness about viral vector vaccines among individuals are also anticipated to facilitate market growth in the upcoming years.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Viral Vector Manufacturing Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Cognate BioServices Inc. (Charles River Laboratories International Inc.), F. Hoffmann-La Roche AG, FinVector Oy, FUJIFILM Holdings Corporation, Kaneka Eurogentec S.A. (Kaneka Corporation), Lonza Group AG, Merck KGaA, Oxford Biomedica plc, REGENXBIO Inc., Sanofi S.A., Thermo Fisher Scientific Inc. and uniQure N.V.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/viral-vector-manufacturing-market
The report has segmented the market on the basis of region, type, disease, application and end user
Breakup by Type:
- Adenoviral Vectors
- Adeno-associated Viral Vectors
- Lentiviral Vectors
- Retroviral Vectors
Breakup by Disease:
- Genetic Disorders
- Infectious Diseases
Breakup by Application:
- Gene Therapy
Breakup by End User:
- Pharmaceutical and Biopharmaceutical Companies
- Research Institutes
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5016&flag=F
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800